STAGE III RENAL CELL CANCER AJCC V7
Clinical trials for STAGE III RENAL CELL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III RENAL CELL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III RENAL CELL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo aims to starve cancer cells in Late-Stage tumors
Disease control OngoingThis early-phase trial tests the safety and best dose of two drugs—MK-2206 and hydroxychloroquine—given together to people with advanced solid tumors, melanoma, prostate, or kidney cancer. The goal is to see if blocking certain cell signals and a process called autophagy can slow…
Matched conditions: STAGE III RENAL CELL CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Immunotherapy before kidney surgery shows promise in preventing cancer return
Disease control OngoingThis study tests whether giving the immunotherapy drug nivolumab before and after kidney cancer surgery can prevent the cancer from returning. About 819 people with localized kidney cancer that has not spread far are participating. The goal is to see if adding nivolumab to standa…
Matched conditions: STAGE III RENAL CELL CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC